The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Le Berre, C., Honap, S., & Peyrin-Biroulet, L. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00966-2 · Cited by 1,643
Danese, S., Vermeire, S., Zhou, W., Pangan, A. L., Siffledeen, J., Greenbloom, S., Hébuterne, X., D'Haens, G., Nakase, H., Panés, J., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00581-5 · Cited by 643
Large-scale plasma proteomics comparisons through genetics and disease associations
Eldjarn, G. H., Ferkingstad, E., Lund, S. H., Helgason, H., Magnusson, O. T., Gunnarsdottir, K., Olafsdottir, T. A., Halldorsson, B. V., Olason, P. I., Zink, F., et al. (2023) · Nature · doi:10.1038/s41586-023-06563-x · Cited by 583
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., Sánchez-Martinez, H., & Gonzalez-Granado, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021526 · Cited by 580
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., D’Haens, G., Wolf, D. C., Jovanovic, I., Hanauer, S. B., Ghosh, S., Petersen, A., Hua, S. Y., Lee, J. H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2033617 · Cited by 569
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00566-7 · Cited by 490
Feagan, B. G., Danese, S., Loftus, E. V., Vermeire, S., Schreiber, S., Ritter, T., Fogel, R., Mehta, R., Nijhawan, S., Kempiński, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00666-8 · Cited by 462
Sandborn, W. J., Vermeire, S., Peyrin-Biroulet, L., Dubinsky, M. C., Panes, J., Yarur, A., Ritter, T., Baert, F., Schreiber, S., Sloan, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00061-2 · Cited by 365
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
D’Haens, G., Dubinsky, M., Kobayashi, T., Irving, P. M., Howaldt, S., Pokrotnieks, J., Krueger, K., Laskowski, J., Li, X., Lissoos, T., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2207940 · Cited by 361
Buie, M. J., Quan, J., Windsor, J. W., Coward, S., Hansen, T. M., King, J. A., Kotze, P. G., Gearry, R. B., Ng, S. C., Mak, J. W. Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.06.030 · Cited by 288
Agrawal, M., Spencer, E. A., Colombel, J.-F., & Ungaro, R. C. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.063 · Cited by 261
Uzzan, M., Martin, J. C., Mesin, L., Livanos, A. E., Castro-Dopico, T., Huang, R., Petralia, F., Magri, G., Kumar, S., Zhao, Q., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01680-y · Cited by 255
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
Sandborn, W. J., D’Haens, G. R., Reinisch, W., Panés, J., Chan, D., Gonzalez, S., Weisel, K., Germinaro, M., Frustaci, M. E., Yang, Z., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.047 · Cited by 206
Vermeire, S., D’Haens, G., Baert, F., Danese, S., Kobayashi, T., Loftus, E. V., Bhatia, S., Agboton, C., Rosario, M., Chen, C., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab133 · Cited by 178
Zhang, X., Yuan, Z., Wu, J., He, Y., Lu, G., Zhang, D., Zhao, Y., Wu, R., Lv, Y., Cai, K., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c04819 · Cited by 170
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
Liu, J., Di, B., & Xu, L.-L. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.07.001 · Cited by 166
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease
Sands, B. E., Peyrin‐Biroulet, L., Kierkuś, J., Higgins, P., Fischer, M., Jairath, V., Hirai, F., D’Haens, G., Belin, R. M., Miller, D. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.10.050 · Cited by 164
Positioning and usefulness of biomarkers in inflammatory bowel disease
Sakurai, T., & Saruta, M. (2023) · Digestion · doi:10.1159/000527846 · Cited by 156
Yang, Z., Liu, F., Zhu, X., Suo, F., Jia, Z., & Yao, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i24.3609 · Cited by 153
Gui, X., Bazarova, A., del Amor, R., Vieth, M., de Hertogh, G., Villanacci, V., Zardo, D., Parigi, T. L., Røyset, E. S., Shivaji, U. N., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326376 · Cited by 136
Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
Kuwada, T., Shiokawa, M., Kodama, Y., Ota, S., Kakiuchi, N., Nannya, Y., Yamazaki, H., Yoshida, H., Nakamura, T., Matsumoto, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.019 · Cited by 132
Han, B., Lv, X., Liu, G., Li, S., Fan, J., Chen, L., Huang, Z., Lin, G., Xu, X., Huang, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2232143 · Cited by 128
Henn, M. R., O’Brien, E. J., Diao, L., Feagan, B. G., Sandborn, W. J., Huttenhower, C., Wortman, J. R., McGovern, B., Wang‐Weigand, S., Lichter, D. I., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.048 · Cited by 126
Vermeire, S., Chiorean, M. V., Panés, J., Peyrin‐Biroulet, L., Zhang, J., Sands, B. E., Lazin, K., Klassen, P., Naik, S. U., Cabell, C. H., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab016 · Cited by 116
Massimino, L., Lamparelli, L. A., Houshyar, Y., D’Alessio, S., Peyrin‐Biroulet, L., Vetrano, S., Danese, S., & Ungaro, F. (2021) · Nature Computational Science · doi:10.1038/s43588-021-00114-y · Cited by 112
Danese, S., Kłopocka, M., Scherl, E., Romatowski, J. A., Allegretti, J. R., Peeva, E., Vincent, M. S., Schoenbeck, U., Ye, Z., Hassan‐Zahraee, M., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.011 · Cited by 107
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
Livanos, A. E., Dunn, A., Fischer, J., Ungaro, R. C., Turpin, W., Lee, S.-H., Rui, S., Valle, D. M. D., Jougon, J., Martínez-Delgado, G., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.12.042 · Cited by 107
Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study
Sands, B. E., Feagan, B. G., Sandborn, W. J., Schreiber, S., Peyrin‐Biroulet, L., Colombel, J., Rossiter, G., Usiskin, K., Ather, S., Zhan, X., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000493 · Cited by 98
Danese, S., Colombel, J., Lukáš, M., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00294-6 · Cited by 97
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Peyrin‐Biroulet, L., Sandborn, W. J., Panaccione, R., Domènech, E., Pouillon, L., Siegmund, B., Danese, S., & Ghosh, S. K. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211059954 · Cited by 78
Ferrante, M., Feagan, B. G., Panés, J., Baert, F., Louis, E. J., Dewit, O., Kaser, A., Duan, W. R., Pang, Y., Lee, W., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab093 · Cited by 75
Microelectrode miRNA Sensors Enabled by Enzymeless Electrochemical Signal Amplification
Wang, T., Viennois, É., Merlin, D., & Wang, G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00780 · Cited by 73
FXR mediates ILC-intrinsic responses to intestinal inflammation
Fu, T., Li, Y., Oh, T. G., Cayabyab, F., He, N., Tang, Q., Coulter, S., Truitt, M., Medina, P., He, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213041119 · Cited by 68
The role of bile acid receptor TGR5 in regulating inflammatory signalling
Ye, D., He, J., & He, X. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13361 · Cited by 67
Stidham, R. W., Cai, L., Cheng, S., Rajaei, F., Hiatt, T., Wittrup, E., Rice, M. D., Bishu, S., Wehkamp, J., Schultz, W., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2023.09.049 · Cited by 63
Exosomes in Intestinal Inflammation
Ayyar, K. K., & Moss, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.658505 · Cited by 58
Croft, A. R., Lord, A., & Radford‐Smith, G. L. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac014 · Cited by 58
Soomro, S., Venkateswaran, S., Vanarsa, K., Kharboutli, M., Nidhi, M., Susarla, R., Zhang, T., Sasidharan, P., Lee, K. H., Rosh, J. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24235-0 · Cited by 55
Serum biomarkers confirming stable remission in inflammatory bowel disease
Kessel, C., Lavric, M., Weinhage, T., Brueckner, M., de Roock, S., Däbritz, J., Weber, J., Vastert, S. J., & Foell, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-86251-w · Cited by 54
Danese, S., Panaccione, R., Abreu, M. T., Rubin, D. T., Ghosh, S. K., Dignass, A. U., Afzali, A., Wolf, D. C., Chiorean, M. V., Vermeire, S., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad146 · Cited by 54
Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
Almeqdadi, M., & Gordon, F. D. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.013 · Cited by 54
Byrne, M. F., Panaccione, R., East, J. E., Iacucci, M., Parsa, N., Kalapala, R., Reddy, D. N., Ramesh Rughwani, H., Singh, A. P., Berry, S. K., et al. (2023) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac152 · Cited by 51
Rydell, N., Ekoff, H., Hellström, P. M., & Movérare, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071881 · Cited by 49
Zhou, Y. Y., Yang, M., Yan, X., Zhang, L., Lü, N., Ma, Y., Zhang, Y., Cui, M., Zhang, M., & Zhang, M. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c09342 · Cited by 48
Viennois, É., Zhao, Y., Han, M. K., Xiao, B., Zhang, M., Prasad, M. A., Wang, L., & Merlin, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-02782-1 · Cited by 47
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome
McCoubrey, L. E., Seegobin, N., Sangfuang, N., Moens, F., Duyvejonck, H., Declerck, E., Dierick, A., Marzorati, M., & Basit, A. W. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.016 · Cited by 46
Li, M., Wu, Y.-Z., Jian-guo, Q., Lei, J.-X., Li, M., Xu, N., Liu, Y., Jin, Z., Su, Z., Lee, S. M., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116430 · Cited by 45
Wang, J., Goren, I., Yang, B., Lin, S., Li, J., Elias, M. G., Fiocchi, C., & Rieder, F. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16741 · Cited by 43
Masi, L., Capobianco, I., Magrì, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147991 · Cited by 42
The role of fatty acids in Crohn's disease pathophysiology – An overview
Piotrowska, M., Binienda, A., & Fichna, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111448 · Cited by 37
Choden, T., Cohen, N. A., & Rubin, D. T. (2022) · PubMed Central · Cited by 34
Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
Chu, X., Biao, Y., Liu, C., Zhang, Y., Liu, C., Zheng, J., Guo, Y., & Gu, Y. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02938-6 · Cited by 34
Vitali, F., Morgenstern, N., Eckstein, M., Atreya, R. N., Waldner, M. J., Hartmann, A., Neurath, M. F., & Räth, T. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2022.08.023 · Cited by 33
Sałaga, M., Bartoszek, A., Binienda, A., Krajewska, J. B., Fabisiak, A., Mosińska, P., Dziedziczak, K., Niewinna, K., Talar, M., Tarasiuk, A., et al. (2021) · Nutrients · doi:10.3390/nu13082716 · Cited by 32
Diagnostic value of anti-integrin αvβ6 antibodies in ulcerative colitis
Marafini, I., Laudisi, F., Salvatori, S., Lavigna, D., Venuto, C., Giannarelli, D., & Monteleone, G. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.06.024 · Cited by 31
Pregnancy and medications in inflammatory bowel disease
Cao, R. H., & Grimm, M. C. (2020) · Obstetric Medicine · doi:10.1177/1753495x20919214 · Cited by 28
Fabián, O., Bajer, L., Drastich, P., Harant, K., Sticová, E., Ďásková, N., Módos, I., Tichánek, F., & Cahová, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119386 · Cited by 28
Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease
Goll, R., Moe, Ø. K., Johnsen, K.-M., Meyer, R., Friestad, J., Gundersen, M. D., Kileng, H., Johnsen, K., & Florholmen, J. R. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02559-5 · Cited by 25
Zhang, L.-S., Zhang, Z.-S., Wu, Y.-Z., Guo, B., Li, J., Huang, X.-Q., Zhang, F.-M., Li, M., Yang, P.-C., & Zheng, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111778 · Cited by 25
Cannatelli, R., Bazarova, A., Furfaro, F., Parigi, T. L., Zardo, D., Nardone, O. M., Spaggiari, P., Villanacci, V., Cadei, M., Labarile, N., et al. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2022.02.012 · Cited by 24
Sakurai, T., Akita, Y., Miyashita, H., Miyazaki, R., Maruyama, Y., Saito, T., Shimada, M., Yamasaki, T., Arihiro, S., Kato, T., et al. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15782 · Cited by 21
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
Besendorf, L., Müller, T. M., Geppert, C., Schneider, I., Mühl, L., Atreya, I., Vitali, F., Atreya, R. N., Neurath, M. F., & Zundler, S. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221098899 · Cited by 17
Titus, A. S. C. L. S., Vanarsa, K., Soomro, S., Patel, A., Prince, J., Kugathasan, S., & Mohan, C. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100487 · Cited by 17
Suilik, H. A., Jaber, F. S., Abuelazm, M. T., Ramadan, A., Elzeftawy, M. A., Elrosasy, A., Youssef, R. A., Abdelazeem, B., Hashash, J. G., Farraye, F. A., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01829-6 · Cited by 16
Magalhães, D., Peyrin‐Biroulet, L., Estevinho, M. M., Danese, S., & Magro, F. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231155987 · Cited by 15
Iborra, M., Ferreiro‐Iglesias, R., Dolores, M.-A. M., Gismero, F. M., Mínguez, A., Porto-Silva, S., Ramírez, L. G., de la Filia, I. G., Aguas, M., Nieto‐García, L., et al. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2278427 · Cited by 15
Tursi, A., Mocci, G., Scaldaferri, F., Napolitano, D., Maresca, R., Pugliese, D., Semprucci, G., Savarino, E. V., Cuomo, A., Donnarumma, L., et al. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2309300 · Cited by 14
Hagiwara, S., Abe, N., Hosoi, K., Hara, T., Ishige, T., Shimizu, H., Mizuochi, T., Kakiuchi, T., Kunisaki, R., Matsuoka, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-37145-6 · Cited by 13
Awan, H., Fatima, U., Eaw, R., Knox, N., & Alrubaiy, L. (2023) · Cureus · doi:10.7759/cureus.37609 · Cited by 12
Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
Rezazadeh, F., Ramos, N., Saliganan, A.-D., Hallak, N. A., Chen, K., Mohamad, B., Wiesend, W. N., & Viola, N. T. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265649 · Cited by 11
Steroids in inflammatory bowel disease: a clinical review
Hussenbux, A., & Silva, A. D. (2021) · Journal of Prescribing Practice · doi:10.12968/jprp.2021.3.3.107 · Cited by 10
Huang, X., Liu, Y., Zhou, Z., Pan, Y., Zhang, Y., Gao, C., & He, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1227998 · Cited by 10
Oka, A., Kawashima, K., Kishimoto, K., Kotani, S., Fukunaga, M., Fukuba, N., Mishima, Y., Oshima, N., Ishimura, N., Awoniyi, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51580-z · Cited by 10
Ruan, G., Jin, X., Zhou, W. X., You, Y., Iacucci, M., Ghosh, S. K., Gui, X. Y., Ji, L., & Qian, J. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13126 · Cited by 9
Liu, L., Pu, D., Wang, D., Zhang, M., Zhou, C., Zhang, Z., & Feng, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905133 · Cited by 7
Acharya, K., Bhardwaj, V., Chuahan, I., Mushfiq, S., Bhatt, S. M., & Lamba, B. M. (2023) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1411 · Cited by 7
Trasolini, R. P., Zhu, K., Klemm, N. K., Park, S., & Salh, B. S. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2021.10.006 · Cited by 6
Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach
Assadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad241 · Cited by 5
Today and tomorrow: the use of biomarkers in inflammatory bowel disease
Rowan, C. R., & Ingram, R. J. M. (2023) · Canadian IBD Today · doi:10.58931/cibdt.2023.1320 · Cited by 1
Metadata
- Authors
- Wangchuk, P., Yeshi, K., & Loukas, A.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 45
- Issue
- 10
- Pages
- 892-903
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W4402412196
- Cited by
- 333
- References
- 81
- FWCI
- 31.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.